News & Events
Good news for people with MS in Poland
Polish authorities reimburse two disease modifying drugs
Practical employment resources in Ireland
MS Ireland has launched new resources for people with MS and employers
MS Helpline celebrates 25 years of supporting people affected by MS in the UK
This year marks the 25th anniversary of the UK MS Society’s helpline.
Effects of an immune system gene on MS subtypes and MRI
HLA alleles are found to be associated with brain atrophy and a younger age of MS onset…
A new gene target for progressive MS
A mutation in a gene called NR1H3 could increase the risk of progressive MS
Mitoxantrone and risk of cancer in MS
German study asks whether recipients of mitoxantrone are more likely than the general population to develop cancers
Stem cell treatment halts MS progression
Rebooting immune system provides long term relief for aggressive relapsing MS in Canadian study
World MS Day makes an impact across the globe
From Canada to Pakistan people affected by MS raised their voices and raised awareness
ECTRIMS support for joint McDonald fellowship
Strengthening our collaboration with ECTRIMS
Second Scientific Congress of the International Progressive MS Alliance
Challenges and next steps considered
Rebound syndrome after stopping fingolimod
Researchers find that suddenly stopping fingolimod may lead to severe worsening of symptoms in MS
Use of metabolic syndrome drugs in multiple sclerosis
Drugs used for metabolic syndrome may reduce MS activity in people with MS and obesity